Morgan Stanley’s Revelation Biosciences REVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
0
-6
| -100% | -$3 | – | 8195 |
|
|
2024
Q4 | $3 | Hold |
6
| – | -$5 | ﹤0.01% | 7947 |
|
|
2024
Q3 | $5 | Buy |
6
+1
| +20% | -$10 | ﹤0.01% | 7888 |
|
|
2024
Q2 | $10 | Hold |
5
| – | -$14 | ﹤0.01% | 7780 |
|
|
2024
Q1 | $14 | Sell |
5
-241
| -98% | -$124 | ﹤0.01% | 7747 |
|
|
2023
Q4 | $124 | Buy |
246
+123
| +100% | -$85 | ﹤0.01% | 7423 |
|
|
2023
Q3 | $85 | Hold |
123
| – | -$116 | ﹤0.01% | 7457 |
|
|
2023
Q2 | $116 | Hold |
123
| – | -$160 | ﹤0.01% | 7486 |
|
|
2023
Q1 | $160 | Sell |
123
-4,166
| -97% | -$815 | ﹤0.01% | 7531 |
|
|
2022
Q4 | $815 | Hold |
4,289
| – | -$1K | ﹤0.01% | 7496 |
|
|
2022
Q3 | $1K | Hold |
4,289
| – | -$5K | ﹤0.01% | 7593 |
|
|
2022
Q2 | $5K | Hold |
4,289
| – | -$5K | ﹤0.01% | 7405 |
|
|
2022
Q1 | $5K | Buy |
4,289
+4,289
| – | – | ﹤0.01% | 7587 |
|